AC
DCPH

Athanor Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Athanor Capital’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,290
Closed -$359K – 1081
2020
Q4 		$359K Buy
+6,290
New +$373K 0.01% 535
2020
Q1 		– Sell
-10,979
Closed -$683K – 376
2019
Q4 		$683K Buy
+10,979
New +$522K 0.03% 209

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Athanor Capital's DCPH Position: Q1 2021 in Review

Athanor Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 6,290 shares — an estimated $359K sold.

Athanor Capital first reported a position in DCPH in Q4 2019 and held it in 2 quarters. The position peaked at $683K in Q4 2019. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Athanor Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 6,290 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $359K.
  • Athanor Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Athanor Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $683K in Q4 2019.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.